Does tretinoin make minoxidil work better? What the studies show
Medication

Does tretinoin make minoxidil work better? What the studies show

Not in the one randomised trial, which showed no added benefit. Even so, tretinoin almost tripled minoxidil absorption in one study, and raised an activating enzyme in some people in another.

Summary

Tretinoin almost tripled minoxidil absorption in a study of 19 healthy men, and moved 3 of 7 predicted non-responders to predicted responders in an enzyme study of 20 people. The only randomised trial with hair outcomes (31 men, 18 weeks) found no difference between the once-daily mixture and minoxidil twice daily. A review from June 2026 concludes that the combination isn't supported as a first choice. In Norway tretinoin is prescription-only, and the creams require an exemption from marketing authorisation.

What claim is the tretinoin and minoxidil combination based on?

That tretinoin increases how much minoxidil gets into the skin and how much is converted to the active form, so that more people respond to it.

Minoxidil doesn't work in the form it's sold in. It has to be converted to minoxidil sulfate, and Sharma and colleagues (2019) describe how sulfotransferase enzymes in the outer root sheath of the hair follicle carry out the conversion. Tretinoin is a vitamin A derivative used for acne and sun-damaged skin. That gives two hypotheses: that tretinoin makes the skin more permeable to minoxidil, and that it increases sulfotransferase activity in the hair follicle. Both have been tested in measurements, but neither shows that you get more hair.

On Norwegian packs and in Felleskatalogen (the Norwegian medicines directory) it's spelled "minoksidil", while we use the English spelling here. The practical version for anyone reading about the trend is in the article on the TikTok combination.

How can an enzyme in the hair follicle predict whether minoxidil works?

In a preliminary, retrospective study, the activity of the enzyme SULT1A1 in plucked hair follicles predicted minoxidil response with 95 % sensitivity and 73 % specificity (Goren and colleagues, 2014).

The starting point is that minoxidil on the skin only produces hair growth in some users. Goren's group writes that the effect across the whole population is low, 30 to 40 %, and that anyone who is going to see an effect must use it daily for at least three to four months. They assumed that SULT1A1 activity in the hair follicle is linked to the response. The 2014 study was retrospective, and the authors write that a larger prospective study was under way to confirm it.

A second paper from the same group (2015) analyses its own completed and ongoing studies and concludes that the test rules out 95.9 % of non-responders. So it isn't confirmation from other researchers. Several of the authors are linked to the company Applied Biology in Irvine, California, as the affiliations in the papers show. We haven't read the conflict of interest statements in full text and can't say anything about what the company sells. The test also isn't available in routine clinical practice, according to the 2026 review, so you can't find out which group you belong to.

What did Sharma and colleagues find about tretinoin and sulfotransferase?

That 43 % of those predicted not to respond to minoxidil were converted to predicted responders after five days of tretinoin on the skin (Sharma and colleagues, 2019).

The study measured enzyme activity. It didn't measure hair. According to the description in the 2026 review, 20 adults with hereditary hair loss took part, and a defined area of the scalp was treated with 0.1 % tretinoin once daily for five days. Average SULT1A1 activity didn't rise significantly across the whole group. In those who had low activity at the start, it did rise. Three of seven were moved into the group expected to respond. In those with normal activity, no significant increase was found.

The figures call for caution. The percentage is based on seven people, and one person more or less shifts it by about 14 points. Five days says nothing about what happens after months, and a higher enzyme level isn't the same as more hair. The group itself calls the study the first to describe the interaction between retinoids and minoxidil. We don't have access to the full text and so can't assess the design, control group or conflicts of interest ourselves. The details here on numbers, strength and duration come from the review, not the original paper.

Does tretinoin increase minoxidil absorption through the skin?

Yes, almost threefold in a study of 19 healthy men, compared with 1.3 times with a neutral cream (Ferry and colleagues, 1990).

The study was a three-way randomised crossover study over 20 days. Participants received 1 ml of an aqueous 2 % minoxidil solution twice daily, either alone, together with 0.05 % tretinoin cream once daily, or together with a neutral cream. Water loss through the skin increased with tretinoin, and the authors concluded that increased permeability of the skin's outermost layer explains the rise. Skin biopsies showed no change in the thickness of that layer.

The limitations are clear. The participants were healthy men, not patients with hair loss, the solution was aqueous and 2 %, not the alcohol-based 5 % solution you get at the pharmacy, and the study measured absorption, not hair. Felleskatalogen's text for Recrea Forte confirms the principle: using medicines that alter the skin barrier at the same time, such as tretinoin and anthralin, can lead to increased absorption.

What did the first study from 1986 find?

In a small series of 56 people, tretinoin with 0.5 % minoxidil produced terminal hair growth in 66 % after one year, and tretinoin alone in about 58 % (Bazzano and colleagues, 1986).

It's the oldest data set, and it's the one most often cited. The authors themselves call the results preliminary and write that more work is needed. According to the 2026 review, the series consisted of several small studies from 1983 to 1986, with 12 people on tretinoin alone, 36 on the combination, 5 on a neutral solution and 3 on 0.5 % minoxidil alone. That means the comparison of the combination against minoxidil alone rests on three people.

The minoxidil strength was 0.5 %, a tenth of what you buy today. Two participants dropped out because of hypersensitivity resembling irritant or contact dermatitis. The figures show that tretinoin can produce hair growth in some people, but they give no basis for saying the combination is better than minoxidil alone.

What did the 2007 randomised trial find?

No difference: 5 % minoxidil and 0.01 % tretinoin once daily gave results as good as 5 % minoxidil twice daily, in 31 men (Shin and colleagues, 2007).

The trial was randomised and double-blind. Participants were men aged 28 to 45 with hereditary hair loss, Hamilton-Norwood type III to V. One group used minoxidil twice daily, the other the mixture in the evening and a neutral solution in the morning. According to the review, 29 of 31 completed 18 weeks. Total hair count and the number of thick hairs (not vellus) rose in both groups, with no statistical difference between them, and both the patients' and the doctor's assessments were similar. Itching or local irritation affected 4 of 14 in the minoxidil group and 5 of 15 in the mixture group.

The authors wanted to show that tretinoin could make once-daily minoxidil possible, not that hair counts would be higher. The result points that way, but only for 18 weeks and 29 men. It doesn't answer whether the mixture helps people who don't respond to minoxidil, because that question wasn't asked. There were no women in it either. The review points out that the study used macrophotography and not a standardised phototrichogram, which is considered the gold standard.

What does the latest review from 2026 conclude?

That current evidence doesn't support the combination as a first choice, but that tretinoin can be considered as an add-on, especially in patients who don't respond to minoxidil alone (Maas and colleagues, 2026).

The review is a narrative review by researchers at NYU Grossman School of Medicine, published online on 18 June 2026 in Skin Appendage Disorders. It says clinical data on the combination are minimal, that the one randomised trial showed the same effect as minoxidil alone, and that smaller studies are consistent with some non-responders becoming responders. The authors write that any benefit has to be weighed against increased irritation. They also point out that anti-androgen medicines such as finasteride are recommended before tretinoin, and that no studies have compared the combination with PRP, laser or a hair transplant.

The review also looked at social media. Of 71 posts, 68 (95.8 %) claimed hair growth, 48 (67.6 %) were positive about the interaction itself, and 29 (40.8 %) mentioned irritation. That tells you the trend is positive in tone. It tells you nothing about effect. You can read more about finasteride on the page about finasteride and dutasteride.

Which risks are documented?

Irritation is the most common, while increased absorption, sun sensitivity and risk in pregnancy are things you need to know about before you consider the combination.

  • Irritation: redness, flaking, itching and stinging. In the Shin study the rate was similar in both groups (4 of 14 vs 5 of 15). The review warns that irritation can make people stop.
  • Increased absorption: Felleskatalogen says systemic effects of topical minoxidil haven't been shown at normal dosing, but can't be ruled out with increased absorption. Under interactions, the text names tretinoin as an agent that can increase absorption. The review asks future studies to monitor for signs of increased systemic exposure.
  • Sun: the Zalna text in Felleskatalogen describes increased sensitivity to UV radiation with tretinoin and recommends SPF 30 or higher.
  • Pregnancy: Zalna is contraindicated in pregnancy and in women planning a pregnancy. Recrea Forte must not be used during pregnancy or breastfeeding. The review writes that oral retinoids are known to harm the foetus, that topical use hasn't shown a consistent pattern, but that both agents should be avoided during pregnancy.
  • Single cases: a 1989 case report describes a 55-year-old patient who developed pyogenic granuloma on the scalp after a month of the combination, with no sign of contact allergy on histology. One case says nothing about how often it happens.

What don't we know about tretinoin and minoxidil?

We don't know whether the combination gives more hair than minoxidil alone, which strength and order are best, how it goes over years, or whether it works alongside minoxidil tablets.

  • Benefit: one randomised trial, 31 men, 18 weeks, no difference. The review calls the data equivocal.
  • Dosing and order: the best timing of tretinoin relative to minoxidil is unclear, and applying them separately hasn't been compared with a single mixture.
  • Duration: the longest follow-up in a study with hair outcomes is 18 weeks. The enzyme study lasted five days.
  • Women: the randomised trial only included men.
  • Tablets: the review writes that there is no research on whether tretinoin can boost the effect of minoxidil tablets.
  • Comparison with other treatments: no studies against PRP, laser or a hair transplant.
  • Long-term safety: the review asks new studies to track irritation and signs of increased absorption systematically.

Can you get tretinoin and minoxidil in Norway?

Not as a ready-made combination for hair loss. You can buy 5 % minoxidil without a prescription, while tretinoin requires a prescription and your doctor must apply for an exemption for the creams.

On 15 October 2026 we found one approved medicine containing tretinoin in Felleskatalogen, Zalna (clindamycin and tretinoin, gel, prescription group C), approved for acne in patients aged 12 and over. The tretinoin creams Effederm 0.05 % and Retirides 0.05 % and 0.1 % are listed in Felleskatalogen as dispensing group C and product type «krever godkj. fritak» (requires an exemption from marketing authorisation), and the application is assessed by the pharmacy. The text says the medicines haven't been assessed by the Norwegian health authorities and have no marketing authorisation in Norway.

DMP (Direktoratet for medisinske produkter, the Norwegian Medical Products Agency) writes that an exemption can be granted for an individual patient, that the application must include a medical reason why a product not marketed in Norway is needed, and that the permission covers a set quantity or at most one year. Using tretinoin for hair loss is off-label. Felleskatalogen's search showed no ready-made combination with minoxidil. Whether pharmacies can make up a mixture is something we haven't looked into. For minoxidil at the pharmacy, see Regaine in Norway and minoxidil for hair loss.

What do the studies mean for you in practice?

That tretinoin is a question for your doctor after you've given minoxidil alone a proper chance, not a shortcut from social media.

The mechanism has support from small measurements, but the effect on hair has no support from a large study. If you want to try it, it's a job for a doctor with follow-up, not for a home-made mixture, and never if you're pregnant or could become pregnant. You'll find the practical guide, with questions you can take to your doctor, in Tretinoin and minoxidil: does the TikTok combination help hair loss?. The comparison of minoxidil as a tablet and on the skin is in the study on oral and topical minoxidil. Why medication and surgery are often combined is explained in the article on medication and hair transplants.

Sources

  1. Maas D, Spindler A, Zappi I, et al. Efficacy of Topical Tretinoin and Topical Minoxidil Cotherapy in Androgenetic Alopecia: A Review. Skin Appendage Disorders, 2026 (online 18 June). DOI 10.1159/000553018. Full text: PMC13423365. pubmed.ncbi.nlm.nih.gov/42535115
  2. Sharma A, Goren A, Dhurat R, et al. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Dermatologic Therapy, 2019;32(3):e12915. DOI 10.1111/dth.12915. pubmed.ncbi.nlm.nih.gov/30974011
  3. Shin HS, Won CH, Lee SH, et al. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. American Journal of Clinical Dermatology, 2007;8(5):285-90. DOI 10.2165/00128071-200708050-00003. pubmed.ncbi.nlm.nih.gov/17902730
  4. Bazzano GS, Terezakis N, Galen W. Topical tretinoin for hair growth promotion. Journal of the American Academy of Dermatology, 1986;15(4 Pt 2):880-3. DOI 10.1016/s0190-9622(86)80024-x. pubmed.ncbi.nlm.nih.gov/3771854
  5. Ferry JJ, Forbes KK, VanderLugt JT, Szpunar GJ. Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution. Clinical Pharmacology & Therapeutics, 1990;47(4):439-46. DOI 10.1038/clpt.1990.55. pubmed.ncbi.nlm.nih.gov/2328551
  6. Goren A, Castano JA, McCoy J, Bermudez F, Lotti T. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia. Dermatologic Therapy, 2014;27(3):171-3. DOI 10.1111/dth.12111. pubmed.ncbi.nlm.nih.gov/24283387
  7. Goren A, Shapiro J, Roberts J, et al. Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatologic Therapy, 2015;28(1):13-6. DOI 10.1111/dth.12164. pubmed.ncbi.nlm.nih.gov/25112173
  8. Baran R. Explosive eruption of pyogenic granuloma on the scalp due to topical combination therapy of minoxidil and retinoic acid. Dermatologica, 1989;179(2):76-8. DOI 10.1159/000248316. pubmed.ncbi.nlm.nih.gov/2792494
  9. Felleskatalogen. Recrea Forte «Cooper», liniment 50 mg/ml (summary of product characteristics: interactions, precautions, pregnancy and breastfeeding). felleskatalogen.no/medisin/recrea-forte-cooper-563303
  10. Felleskatalogen. Zalna «Viatris», gel (clindamycin, tretinoin): prescription group C, indication, pregnancy, UV radiation. felleskatalogen.no/medisin/zalna-viatris-588961
  11. Felleskatalogen. Search for «tretinoin» and «effederm», checked 15 October 2026. felleskatalogen.no/medisin/sok?sokord=tretinoin
  12. Direktoratet for medisinske produkter. Informasjon om godkjenningsfritak for leger og tannleger (information on exemptions for doctors and dentists, updated 16.06.2026). dmp.no/godkjenningsfritak/for-leger-og-tannleger

Here we summarise published research and pack information as general information. This text doesn't replace a medical assessment, and it doesn't encourage you to start, stop or adjust a medicine. Tretinoin is prescription-only and has contraindications, including pregnancy. Discuss your choice with your doctor, who knows your medical history and medicines.

Free assessment

Wondering what's possible for your hair?

Send three sharp photos of your hair, from the front, the top and the back. You'll get an honest answer on what can be done, roughly how many grafts it would take and what it costs.

  • Free and with no obligation
  • Photos are assessed by the clinic's medical team
  • Replies usually within an hour in the daytime
See more before and after photos

3 photos: from the front, from above and from the back (crown). The photos are what make the analysis accurate. If you don't have them to hand, you can send them on WhatsApp later.

Your details are kept confidential, and the clinic will reply to you on WhatsApp or by email.

What does this mean for you?

A study tells you something about groups. Only a doctor who has seen your photos can say what applies to your hair. The medical team at the clinic at the top of our ranking offers a free assessment.

Goes to the clinic at the top of our ranking.

Ask the clinic on WhatsAppA reply from the clinic, usually within an hour during the day.
Ask the clinic